These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36315910)

  • 21. Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.
    Tchernychev B; Li H; Lee SK; Gao X; Ramanarasimhaiah R; Liu G; Hall KC; Bernier SG; Jones JE; Feil S; Feil R; Buys ES; Graul RM; Frenette PS; Masferrer JL
    Br J Pharmacol; 2021 Sep; 178(17):3463-3475. PubMed ID: 33864386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
    Keleku-Lukwete N; Suzuki M; Otsuki A; Tsuchida K; Katayama S; Hayashi M; Naganuma E; Moriguchi T; Tanabe O; Engel JD; Imaizumi M; Yamamoto M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12169-74. PubMed ID: 26371321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gut microbiome in sickle cell disease: Characterization and potential implications.
    Brim H; Taylor J; Abbas M; Vilmenay K; Daremipouran M; Varma S; Lee E; Pace B; Song-Naba WL; Gupta K; Nekhai S; O'Neil P; Ashktorab H
    PLoS One; 2021; 16(8):e0255956. PubMed ID: 34432825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian period 2: a missing beneficial factor in sickle cell disease by lowering pulmonary inflammation, iron overload, and mortality.
    Adebiyi MG; Zhao Z; Ye Y; Manalo J; Hong Y; Lee CC; Xian W; McKeon F; Culp-Hill R; D' Alessandro A; Kellems RE; Yoo SH; Han L; Xia Y
    FASEB J; 2019 Sep; 33(9):10528-10537. PubMed ID: 31260634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. End Organ Affection in Sickle Cell Disease.
    Bathla T; Lotfollahzadeh S; Quisel M; Mehta M; Malikova M; Chitalia VC
    Cells; 2024 May; 13(11):. PubMed ID: 38891066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β1 Reduces Neutrophil Adhesion and Prevents Acute Vaso-Occlusive Processes in Sickle Cell Disease Mice.
    Torres LS; Chweih H; Fabris FCZ; Gotardo EMF; Leonardo FC; Saad STO; Costa FF; Conran N
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
    Rossato P; Federti E; Matte A; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Andolfo I; Iolascon A; Rottensteiner H; Gritsch H; Scheiflinger F; Hoellriegl W; Franceschi L
    Haematologica; 2022 Nov; 107(11):2650-2660. PubMed ID: 35443560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac complications of sickle cell disease in children].
    Astadicko I; Dresse MF; Seghaye MC
    Rev Med Liege; 2018 Nov; 73(11):550-556. PubMed ID: 30431243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
    Novelli EM; Kato GJ; Ragni MV; Zhang Y; Hildesheim ME; Nouraie M; Barge S; Meyer MP; Hassett AC; Gordeuk VR; Gladwin MT; Isenberg JS
    Am J Hematol; 2012 Mar; 87(3):326-30. PubMed ID: 22318901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
    Tolu SS; Van Doren L
    Transfus Apher Sci; 2022 Oct; 61(5):103533. PubMed ID: 36058780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.
    Vats R; Tutuncuoglu E; Pradhan-Sundd T; Tejero J; Shaw GD; Sundd P
    Exp Hematol; 2020 Apr; 84():1-6.e1. PubMed ID: 32243995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hamali HA
    Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement involvement in sickle cell disease.
    Meuleman MS; Roumenina LT; Grunenwald A
    Presse Med; 2023 Dec; 52(4):104205. PubMed ID: 37972851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response.
    Nekhai S; Kumari N
    Expert Rev Hematol; 2022 Mar; 15(3):253-263. PubMed ID: 35322747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of blood rheology in sickle cell disease.
    Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
    Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular pathophysiology of sickle cell disease.
    Connes P; Renoux C; Joly P; Nader E
    Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.